Welcome to LookChem.com Sign In|Join Free
  • or
spiro[benzofuran-2(3H),1'-Methyl-4'-piperidine] hydrobroMide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

71916-97-7

Post Buying Request

71916-97-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71916-97-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 71916-97-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,9,1 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 71916-97:
(7*7)+(6*1)+(5*9)+(4*1)+(3*6)+(2*9)+(1*7)=147
147 % 10 = 7
So 71916-97-7 is a valid CAS Registry Number.

71916-97-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]

1.2 Other means of identification

Product number -
Other names 5-chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidine]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71916-97-7 SDS

71916-97-7Relevant academic research and scientific papers

Spirocyclic compounds, potent CCR1 antagonists

Hossain, Nafizal,Ivanova, Svetlana,Bergare, Jonas,Eriksson, Tomas

, p. 1883 - 1886 (2013/04/10)

Conformationally constrained spirocycles (17-23) and (31-36) were synthesised. In vitro data revealed that these compounds are CCR1 antagonists with sub-nanomolar potency. In a functional assay 22, 23 and 36 inhibited CCR1 mediated chemotaxis with an ICs

PROCESS FOR THE PREPARATION OF CYCLIC SPIROPIPERIDINES

-

Page/Page column 15, (2009/03/07)

The present invention relates to new processes for the preparation of compounds of formula I, especially the compound 2-{2-Chloro-5-{[(2S)-3-(5-chloro-1'H,3H-spiro[1- benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-4-5 [(methylamino)carbonyl]phenoxy}-2-methylpropanoic acid and to new intermediates useful in the preparation thereof.

A PROCESS FOR THE PREPARATION OF INTERMEDIATES AND THEIR US IN THE SYNTHESIS OF SPIROPIPERIDINE COMPOUNDS

-

Page/Page column 24-25, (2009/03/07)

The present invention relates to new processes for the preparation of compounds of formula I, especially the compound 2-{2-Chloro-5-{[(2S)-3-(5-chloro-1'H,3H-spiro[l- benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-4-5[(methylamino)carbonyl]phenoxy}-2-methylpropanoic acid and to new intermediates useful in the preparation thereof.

NOVEL TRICYCLIC SPIROPIPERIDINE COMPOUNDS, THEIR SYNTHESIS AND THEIR USES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

-

Page/Page column 73-74, (2008/06/13)

Compounds of formula (I) wherein R1, R3, R4, R5, R6, R7, and R10 are as defined in the specification, are described. The present invention also relates to pharmaceutical composition comprising said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. Beside, the invention relates to salts and polymorphic forms of the new compounds as well as the preparation thereof.

NOVEL COMPOUNDS

-

Page/Page column 25-26, (2008/06/13)

The invention provides compounds of formula (I) wherein m, R1, n, R2, q, X, Y, Z, t, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their

NOVEL COMPOUNDS

-

Page/Page column 20-21, (2010/02/12)

The invention provides compounds of formula (I) wherein m, R1, n, R2, q, X, Y, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their prepa

NOVEL TRICYCLIC SPIRODERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

-

Page/Page column 23-24, (2008/06/13)

The invention provides compounds of formula (I) wherein m, R1, n, R2, q, p, X, Y, R3, R4, t and, R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

NOVEL TRICYCLIC SPIROPIPERIDINES OR SPIROPYRROLIDINES

-

, (2008/06/13)

The invention provides compounds of formula (I) wherein m, R1, n, R2, q, X, Y, Z, R3, R4, R5, R6, R7, R8, t and R9 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Synthesis of 2,3-Dihydrospiro and 2,3-dihydrospiro

Effland, Richard C.,Gardner, Beth Ann,Strupczewski, Joseph

, p. 811 - 814 (2007/10/02)

The synthesis of 2,3-dihydrospiro 3 and 2,3-dihydrospiro 6 is described.The synthesis was achieved by a Grignard reaction of a 2-fluorobenzylhalide with an appropriate cycloazaalkyl ketone to yield

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 71916-97-7